GALT compared with ECOR: revenue, margins and what each company keeps, and the suppliers and customers both name

GALTGalectin Therapeutics Inc

Mkt capRevenueRevenue

ECORelectroCore, Inc.

Mkt capRevenueRevenue

Compare

GALTGalectin Therapeutics Inc

ECORelectroCore, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GALT: latest quarter not drawable. ECOR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GALT 6

—Perspectum Diagnosticsunlistedsupplier

—Covance (now known as Fortrea)unlistedsupplier

—Dr. Ari Rosenbergunlistedsupplier

—Dr. Chetan Bettegowdaunlistedsupplier

2 more · GALT chain ›

Shared 0

No shared counterparties.

Only ECOR 1

—Joerns Healthcareunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

GALT, solidECOR, dashed

GALTGalectin Therapeutics Inc

3.31▼−5.94%· post 3.31

Mkt cap$334.8MRevenue—Revenue—

ECORelectroCore, Inc.

7.50▼−7.52%· post 7.50

ClosedOct 30 '26

Mkt cap$67.8MRevenue$9MQ2 FY26Revenue$32MFY25

Compare

ClosedOct 30 '26

GALTGalectin Therapeutics Inc

ECORelectroCore, Inc.

3.31▼−5.94%post 3.31

Price

7.50▼−7.52%post 7.50

$334.8M

Mkt cap

$67.8M

—

Revenue

$9MQ2 FY26

—

Revenue

$32MFY25

GALT3.31▼−5.94%vsECOR7.50▼−7.52%ClosedOct 30 '26